SAGIMET BIOSCIENCES INC

SAGIMET BIOSCIENCES INSIDER BUYS Surge as Director George Accumulates Amid Rally Ahead of Q4 Data Release

Insider Kemble George’s sharp buying surge signals confidence ahead of Sagimet’s Q4 clinical data, hinting at a near‑term rally.

SAGIMET BIOSCIENCES INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/08/2026, 22:24

3 minutes to read

SAGIMET BIOSCIENCES INC. Insider George Buys 20K Shares as Stock Climbs 8.7% to 52‑Week High, Signaling Confidence Ahead of Dermatology Trial

Insider buying surges at SAGIMET as Kemble George snaps up shares amid an 8.68% price jump, signaling confidence in its Phase‑3 dermatology trial and strong cash runway.

SAGIMET BIOSCIENCES INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/08/2026, 01:57

3 minutes to read